Extract from the Register of European Patents

EP Citations: EP3129061

Cited inInternational search
Type:Patent literature
Publication No.:WO2010019718  [Y]
 (CALIFORNIA INST OF TECHN et al.) [Y] 1-19 * See abstract; formulas XXV-XXXI; paragraphs [0068], [0041], [0042], [00105]-[00111], [00149], [00154]-[00167] examples 22, 25; claims 1, 2, 8-26, 30, 34 ; figures 1, 2 *
Type:Patent literature
Publication No.:US2014249202  [PY]
 (DAVIS MARK E et al.) [PY] 1-19 * See abstract; formulas XXV-XXXI; examples 5, 23; tables 3-7; claims 1-23 *
Type:Non-patent literature
Publication information:[Y]   KONKIMALLA, V. BADIREENATH ET AL.: "Inhibition of epidermal growth factor receptor-overexpressing cancer cells by camptothecin, 20-(N,N-diethyl) glycinate.", BIOCHEMICAL PHARMACOLOGY, vol. 80, no. 1, 2010, pages 39 - 49, XP027027188, ISSN: 0006-2952 [Y] 1-19 * See abstract; figures 1-8 *
Type:Non-patent literature
Publication information:[Y]   HAN, H. ET AL.: "Targeted nanoparticles assembled via complexation of boronic- acid-containing targeting moieties to diol-containing polymers.", BIOCONJUG. CHEM., vol. 24, no. 4, 2013, pages 669 - 677, XP055230363, ISSN: 1043-1802 [Y] 1-19 * See abstract; schemes 1-4; tables 1-4 *
DOI: http://dx.doi.org/10.1021/bc300640j
Type:Non-patent literature
Publication information:[Y]   HAN, H. ET AL.: "Single-Antibody, Targeted Nanoparticle Delivery of Camptothecin.", MOL. PHARMACEUTICS., vol. 10, no. 7, 2013, pages 2558 - 2567, XP055191493, ISSN: 1543-8384 [Y] 1-19 * See abstract; scheme 1; tables 1-4; figures 1-4 *
DOI: http://dx.doi.org/10.1021/mp300702x
Type:Non-patent literature
Publication information:[A]   DATABASE NCBI GenBank [O] 15 March 2015 (2015-03-15), SCHAEFFER, D ET AL: "Homo sapiens epidermal growth factor receptor (EGFR), transcript variant 1, mRNA", XP055230367, retrieved from ncbi Database accession no. NM_005228.3 [A] 1-19 * See the whole document. *